Total abdominal hysterectomy is a reasonable option for
patients who do not wish to preserve their fertility. Hysterectomy
is particularly advisable for patients >40 years
whose risk of developing GTD is significantly increased.
Though hysterectomy eliminates the risk of locally invasive
disease, it does not prevent metastases and reduces
the subsequent risk of persistent trophoblastic disease
by up to 50% (8).
Guidelines from the Royal College of Obstetricians and
Gynecologists and the British Blood Transfusion Society
recommend that all Rhesus-negative women who have
a molar pregnancy should be given 250 IU anti-D immunoglobulin
after surgical evacuation